1st RSV vaccine could be approved by August, pending FDA review

Brasil Notícia Notícia

1st RSV vaccine could be approved by August, pending FDA review
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 6abc
  • ⏱ Reading Time:
  • 13 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 63%

The FDA will decide whether or not to approve an RSV vaccine designed to protect newborns by August 2023.

that the U.S. Food and Drug Administration has accepted its application for review and will make a decision on whether or not to approve the vaccine by August 2023.

Pfizer's protein-based RSV vaccine works by vaccinating a pregnant person, who then passes on some protective antibodies to the infant.RSV usually causes mild, cold-like symptoms, but can become serious, especially for infants and older adults.

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

6abc /  🏆 250. in US

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

FDA’s own reputation could be restraining its misinfo fightFDA’s own reputation could be restraining its misinfo fightThe government agency responsible for tracking down contaminated peanut butter and defective pacemakers is taking on a new health hazard: online misinformation. It’s an unlikely role for the Food and Drug Administration, a sprawling, century-old bureaucracy that for decades directed most its communications toward doctors and corporations. “Almost no one should be dying of COVID in the U.S. today,” Califf told The Associated Press, noting the government's distribution of free vaccines and antiviral medications.
Consulte Mais informação »

FDA’s own reputation could be restraining its misinfo fightFDA’s own reputation could be restraining its misinfo fightWASHINGTON (AP) — The government agency responsible for tracking down contaminated peanut butter and defective pacemakers is taking on a new health hazard: online misinformation. It’s an unlikely role for the Food and Drug Administration, a sprawling, century-old bureaucracy that for decades directed most its communications toward doctors and corporations.
Consulte Mais informação »

FDA’s own reputation could be restraining its misinfo fightFDA’s own reputation could be restraining its misinfo fightThe U.S. Food and Drug Administration is taking aim at a new health hazard: online misinformation
Consulte Mais informação »

The FDA has recalled more than 300,000 bottles of Starbucks bottled FrappuccinosThe FDA has recalled more than 300,000 bottles of Starbucks bottled FrappuccinosThe bottles of Starbucks' vanilla Frappuccinos may contain pieces of glass, the Food and Drug Administration said.
Consulte Mais informação »

FDA’s own reputation could be restraining its misinformation fightFDA’s own reputation could be restraining its misinformation fightIt’s an unlikely role for the Food and Drug Administration, a sprawling, century-old bureaucracy that for decades directed most its communications toward doctors and corporations.
Consulte Mais informação »

FDA’s own reputation could be restraining its misinfo fightFDA’s own reputation could be restraining its misinfo fightThe government agency responsible for tracking down contaminated peanut butter and defective pacemakers is taking on a new health hazard: online misinformation.
Consulte Mais informação »



Render Time: 2025-03-01 18:17:54